Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

RECKITT BENCKISER GROUP PLC

ClinicalTrials.gov lists RECKITT BENCKISER GROUP PLC as lead sponsor of 34 trials, counting the companies grouped under it.

GB Industry CIK 0001420798
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 7 Disease areas Disease areas 15 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Journals published in Journals published in 34 US granted patents US granted patents 1 Organization relationships Organization relationships 6 Latest dated events Latest dated events 162 Biomarker capability evidence Biomarker capability evidence 4 Companies grouped under this page Companies grouped under this page 7 Disease areas Disease areas 15 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 1 Journals published in Journals published in 34 US granted patents US granted patents 1 Organization relationships Organization relationships 6 Latest dated events Latest dated events 162 Biomarker capability evidence Biomarker capability evidence 4

Rows recorded per section (log scale)

16 sections measured, none recorded

Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers RECKITT BENCKISER GROUP PLC and 7 companies grouped under it: 34 lead-sponsored trials (0 its own, 34 in the grouped companies) and 20 legal-entity registrations (2 its own, 18 in the grouped companies).

Get the RECKITT BENCKISER GROUP PLC report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (7)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
RECKITT BENCKISER HEALTHCARE (UK) LIMITED 34 1
MEAD JOHNSON NUTRITION (CANADA) CO. 0 2
RECKITT BENCKISER (CZECH REPUBLIC), SPOL. S R.O. 0 2
RECKITT BENCKISER HEALTH LIMITED 0 2
RECKITT BENCKISER HEALTHCARE INDIA PRIVATE LIMITED 0 1

Showing 5 of 7 member companies.

Start your 14-day trial Email me all 7 member companies as a PDF

Disease areas (15)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Deglutition Disorders 5
Gastroesophageal Reflux 5
Sexual Dysfunction, Physiological 4
Pain 3
Dyspareunia 2

Showing 5 of 15 disease areas.

Start your 14-day trial Email me all 15 disease areas as a PDF

Trials by start year as sponsor or collaborator (1)

Trials by start year as sponsor or collaborator
Year Trials started
2022 1

No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Journals published in (34)

Shown in this order: most published in first.

Journals published in
Journal Publications
Pain 3
The Physician and sportsmedicine 2
Alimentary pharmacology & therapeutics 1
American family physician 1
Archives of internal medicine 1

Showing 5 of 34 journals.

Start your 14-day trial Email me all 34 journals as a PDF

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
88 12 2025-11-25

Organization relationships (6)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Reckitt Benckiser (United Kingdom) Parent of 4
Reckitt Benckiser (United Kingdom) Ultimate parent of 4
Novotech (Australia) Pty Limited Uses vendor 2
Premier Research Uses vendor 2
Mead Johnson (United States) Parent of 1

Showing 5 of 6 relationships.

Start your 14-day trial Email me all 6 relationships as a PDF

Latest dated events (162)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-07-31 FDA import refusal FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment)
2025-11-25 Patent granted Granted US patents (PatentsView / USPTO)
2025-11-18 Patent granted Granted US patents (PatentsView / USPTO)
2025-11-04 Patent granted Granted US patents (PatentsView / USPTO)
2025-10-12 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 162 events.

Start your 14-day trial Email me the first 50 events as a PDF

Biomarker capability evidence (4)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ATP12A Trial collaborator Named in trial exclusion criteria
ATP4A Trial collaborator Named in trial exclusion criteria
ATP12A Trial collaborator Mentioned in trial text
ATP4A Trial collaborator Mentioned in trial text

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.